The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
Open accessAbstract
BACKGROUND: We evaluated the effectiveness of three treatment strategies for the prevention of a first episode of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus (HIV). METHODS: In an open-label trial, 843 patients with HIV infection and fewer than 200 CD4+ cells per cubic millimeter received zidovudine plus one of three randomly assigned prophylactic agents, beginning with trimethoprim-sulfamethoxazole, dapsone, or aerosolized pentamidine and followed by a defined sequence of other drugs to be used in cases of intolerance. RESULTS: The estimated 36-month cumulative risks of P. carinii pneumonia were 18 percent, 17 percent, and 21 percent in the trimethoprim-sulfamethoxazole, dapsone, and aerosolized-pentamidine groups, respectively (P = 0.22). The difference in risk among treatment strategies was negligible in patients entering the study with 100 or more CD4+ lymphocytes per cubic millimeter. In those entering with fewer than 100 CD4+ cells per cubic millimeter, the risk was 33 percent with aerosolized pentamidine, as compared with 19 percent with trimethoprim-sulfamethoxazole and 22 percent with dapsone (P = 0.04). The lowest failure rates occurred in patients receiving trimethoprim-sulfamethoxazole, and failures were more common with 50 mg of dapsone than with 100 mg. Toxoplasmosis developed in less than 3 percent of patients. Of the patients assigned to the two systemic therapies, only 23 percent were receiving their assigned drug and dose when they completed the study. The median survival was approximately 39 months in all three groups, and the mortality attributable to P. carinii pneumonia was only 1 percent. CONCLUSIONS: In patients with advanced HIV infection, the three treatment strategies we examined have similar effectiveness in preventing P. carinii pneumonia. Strategies that start with trimethoprim-sulfamethoxazole or with high-dose dapsone, rather than aerosolized pentamidine, are superior in patients with fewer than 100 CD4+ lymphocytes per cubic millimeter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fischl, M. A. (1988) · JAMA · doi:10.1001/jama.259.8.1185 · Cited by 422
Hardy, W. D., Feinberg, J., Finkelstein, D. M., Power, M. E., He, W., Kaczka, C., Frame, P. T., Holmes, M., Waskin, H., Fass, R. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272604 · Cited by 346
Self-citationPowderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321102 · Cited by 318
Self-citationLeoung, G. S., Feioal, D. W., Montgomery, A. B., Corkery, K., Wardlaw, L., Adams, M., Busch, D., Gordon, S., Jacobson, M. A., Volberding, P. A., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231201 · Cited by 299
Schneider, M. M. E., Hoepelman, A. I. M., Schattenkerk, J. K. M. E., Nielsen, T. L., van der Graaf, Y., Frissen, J. P. H. J., van der Ende, I. M. E., Kolsters, A. F. P., & Borleffs, J. C. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272603 · Cited by 282
Carr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Penny, R., & Cooper, D. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-106 · Cited by 232
Girard, P.-M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P., Gaudebout, C., Certain, A., Boue, F., Bouvet, E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305273282102 · Cited by 192
Prevention and Treatment of Pneumocystis Pneumonia
Wood, A. J. J., & Masur, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272606 · Cited by 176
A Controlled Study of Inhaled Pentamidine for Primary Prevention of Pneumocystis carinii Pneumonia
Hirschel, B., Lazzarin, A., Chopard, P., Opravil, M., Furrer, H.-J., Rüttimann, S., Vernazza, P., Chave, J.-P., Ancarani, F., Gabriel, V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241602 · Cited by 175
Prevention and Treatment of Pneumocystis Pneumonia
(1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281524 · Cited by 169
Graham, N. M. H., Zeger, S. L., Park, L. P., Saah, A. J., Phair, J., Detels, R., Vermund, S. H., & Ho, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90414-k · Cited by 154
Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS).
Saah, A. J., Hoover, D. R., He, Y., Kingsley, L., & Phair, J. (1994) · PubMed · Cited by 121
Ruskin, J., & LaRiviere, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)93402-u · Cited by 119
de Torres, R. A., Barr, M. R., Thorn, M., Gregory, G., Kiely, S., Chanin, E., Carlo, C., Martin, M., & Thornton, J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90352-p · Cited by 68
Blum, R. N., Miller, L. A., Gaggini, L. C., et al. (1992) · PubMed · Cited by 67
Mallolas, J., Zamora, L., Gatell, J. M., et al. (1993) · PubMed · Cited by 67
Chaisson, R. E. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.10.2009 · Cited by 62
Primary prophylaxis for Pneumocystis carinii pneumonia
Mallolas, J., Zamora, L., Gatell, J. M., et al. (1993) · AIDS · doi:10.1097/00002030-199301000-00009 · Cited by 53
Podzamczer, D., Santín, M., Jimenez, J., et al. (1993) · AIDS · doi:10.1097/00002030-199304000-00008 · Cited by 49
May, T., Beuscart, C., Reynes, J., et al. (1994) · PubMed · Cited by 39
Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis
Slavin, M. A., Hoy, J., Stewart, K., Pettinger, M. B., Lucas, C. R., & Kent, S. J. (1992) · AIDS · doi:10.1097/00002030-199210000-00017 · Cited by 39
Cited by
Toxoplasma gondii: from animals to humans
Tenter, A. M., Heckeroth, A. R., & Weiss, L. M. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00124-7 · Cited by 3,702
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Hellmich, B., Sanchez-Alamo, B., Schirmer, J. H., Berti, A., Blockmans, D., Cid, M. C., Holle, J. U., Hollinger, N., Karadag, O., Kronbichler, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223764 · Cited by 768
Yale, S. H., & Limper, A. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.5 · Cited by 644
Limper, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2008-740st · Cited by 612
Metadata
- Authors
- Bozzette, S. A., Finkelstein, D. M., Spector, S. A., Frame, P., Powderly, W. G., He, W., Phillips, L., Craven, D., van der Horst, C., & Feinberg, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1995-03-16
- Volume
- 332
- Issue
- 11
- Pages
- 693-699
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2336509748
- Cited by
- 332
- References
- 21
- FWCI
- 30.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.